Aardvark Therapeutics (AARD) Interest Coverage Ratio (2024 - 2025)

Aardvark Therapeutics (AARD) reported Interest Coverage Ratio of 990.5 for Q2 2025, up 90.54% sequentially from 10470.0 in Q1 2025.

Aardvark Therapeutics (AARD) Interest Coverage Ratio (2024 - 2025) Analysis & Trends

Aardvark Therapeutics (AARD) has 2 years of Interest Coverage Ratio data on file, last reported at 990.5 in Q2 2025.

For the quarter ending Q2 2025, Interest Coverage Ratio changed N/A year-over-year to 990.5; the trailing twelve-month figure through Jun 2025 stood at 2553.69 (changed N/A YoY), and the FY2025 full-year result was 5.07, down 310.62% from the prior year.
Interest Coverage Ratio grew to 990.5 in Q2 2025, from 10470.0 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 2.98 in Q4 2024 to a low of 10470.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	658.42
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	7.60
4	NuCana	279.75 Bn	279.75 Bn	-	-0.22
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	2.71
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	22.72
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-0.38
10	Aardvark Therapeutics	139.40 Mn	19.44 Mn	-	-

Download Data